Samsung Biologics Q2 2025 Financial Results Released

Samsung Biologics Reports Strong Q2 2025 Financial Results, Advances in ADCs, Digitalization, and Sustainability Samsung Biologics one of the world’s leading contract development and manufacturing organizations (CDMOs), has announced its financial results for the second quarter of fiscal year 2025,…












